Sweden-based life-science group ADDvise has landed an order worth approximately $2.3m through its subsidiary MRC Systems.
The contract, awarded by global engineering firm IPS, covers the design, panelling and installation of a cleanroom and associated accessories for a new pharmaceutical manufacturing facility in the US.
MRC Systems is based in Dubai, but has delivered projects across the globe, in countries such as Saudi Arabia, Oman, Greece.
The company also started a strategic partnership in 2022 to deliver its technology to the US market. The collaboration with Biologics Modular surrounds access to MRC’s cleanroom wall system technology.
Delivery of this new project in the US is slated to begin in 2025 and run through 2026.
ADDvise is an international life‐science player, operating over 20 companies across lab and healthcare business sectors.
The order reflects a growth strategy focused on deploying specialised infrastructure into high-value pharma manufacturing build-outs.
The order provides ADDvise a pathway to repeatable growth in the North American manufacturing sector, especially as pharma companies expand capacity for biologics and advanced therapies.